|
市場調査レポート
商品コード
1729258
日本の医薬品ドラッグデリバリー市場レポート：投与経路、用途、エンドユーザー、地域別、2025年～2033年Japan Pharmaceutical Drug Delivery Market Report by Route of Administration, Application, End User, and Region 2025-2033 |
||||||
カスタマイズ可能
|
|||||||
| 日本の医薬品ドラッグデリバリー市場レポート：投与経路、用途、エンドユーザー、地域別、2025年～2033年 |
|
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 118 Pages
納期: 5～7営業日
|
- 全表示
- 概要
- 目次
日本の医薬品ドラッグデリバリー市場規模は2024年に664億米ドルに達しました。IMARC Groupは、2025年から2033年にかけての成長率（CAGR）は4.43%で、2033年には1,011億米ドルに達すると予測しています。ドラッグデリバリーのイノベーションを促進する個別化医療に対する大手企業の重点の高まりと、ナノテクノロジーにおける数々の進歩が、主に市場成長を牽引しています。
本レポートで扱う主な質問
- 日本の医薬品ドラッグデリバリー市場はこれまでどのように推移し、今後どのように推移するのか？
- COVID-19が日本の医薬品ドラッグデリバリー市場に与えた影響は？
- 日本の医薬品ドラッグデリバリー市場の投与経路別区分は？
- 日本の医薬品ドラッグデリバリー市場の用途別区分は？
- 日本の医薬品ドラッグデリバリー市場のエンドユーザー別の区分は？
- 日本の医薬品ドラッグデリバリー市場のバリューチェーンにおける様々なステージとは？
- 日本の医薬品ドラッグデリバリーの主な促進要因と課題は何か？
- 日本の医薬品ドラッグデリバリー市場の構造と主要プレーヤーは？
- 日本の医薬品ドラッグデリバリー市場における競合の程度は？
目次
第1章 序文
第2章 調査範囲と調査手法
- 調査の目的
- ステークホルダー
- データソース
- 市場推定
- 調査手法
第3章 エグゼクティブサマリー
第4章 日本の医薬品ドラッグデリバリー市場- イントロダクション
- 概要
- 市場力学
- 業界動向
- 競合情報
第5章 日本の医薬品ドラッグデリバリー市場情勢
- 過去および現在の市場動向（2019～2024年）
- 市場予測（2025～2033年）
第6章 日本の医薬品ドラッグデリバリー市場- 投与経路別の内訳
- 経口ドラッグデリバリー
- 注射ドラッグデリバリー
- 局所ドラッグデリバリー
- 眼科ドラッグデリバリー
- 肺ドラッグデリバリー
- 埋め込み型ドラッグデリバリー
- 経粘膜ドラッグデリバリー
- 鼻腔内ドラッグデリバリー
第7章 日本の医薬品ドラッグデリバリー市場- 用途別の内訳
- 感染症
- がん
- 心血管疾患
- 糖尿病
- 呼吸器疾患
- 中枢神経系疾患
- 自己免疫疾患
- その他
第8章 日本の医薬品ドラッグデリバリー市場- エンドユーザー別の内訳
- 病院
- 外来手術センター
- 在宅ケア環境
- 診断センター
- その他
第9章 日本の医薬品ドラッグデリバリー市場- 競合情勢
- 概要
- 市場構造
- 市場企業のポジショニング
- 主要成功戦略
- 競合ダッシュボード
- 企業評価象限
第10章 主要企業のプロファイル
第11章 日本の医薬品ドラッグデリバリー市場- 業界分析
- 促進要因、抑制要因、機会
- ポーターのファイブフォース分析
- バリューチェーン分析
第12章 付録
Japan pharmaceutical drug delivery market size reached USD 66.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 101.1 Billion by 2033, exhibiting a growth rate (CAGR) of 4.43% during 2025-2033. The rising emphasis of leading players on personalized medicine fostering drug delivery innovations and numerous advancements in nanotechnology are primarily driving the market growth.
Pharmaceutical drug delivery is the systematic and controlled administration of medicines to patients with the goal of optimizing the therapeutic results. This involves the utilization of various methods and technologies to ensure precise dosage, improved absorption by the body, and the targeted delivery of pharmaceutical compounds to specific locations within the body. The field of drug delivery is focused on improving the effectiveness, safety, and convenience of treatments while minimizing potential side effects. It encompasses a wide array of approaches, including oral, injectable, transdermal, inhalation, and implantable methods. Currently, pharmaceutical drug delivery is gaining significant traction in reshaping patient care on a global scale by maximizing the advantages of medications and facilitating more personalized and efficient therapeutic solutions.
Japan Pharmaceutical Drug Delivery Market Trends:
The pharmaceutical drug delivery market in Japan is experiencing significant growth driven by several compelling factors. Notably, the rising emphasis on personalized medicine and targeted therapies is a key driver, aligning treatment approaches more closely with individual patient needs. Continuous advancements in drug formulation and delivery technologies are also playing a pivotal role in catalyzing market expansion. Researchers in Japan are consistently exploring innovative strategies, including nanotechnology, liposomes, and microparticles, to enhance drug stability, bioavailability, and controlled release. These innovations enable the development of novel drug delivery systems capable of addressing challenges associated with traditional formulations, such as poor solubility, rapid metabolism, or short half-life, thus driving market growth. Moreover, the increasing prevalence of chronic diseases like diabetes, cardiovascular disorders, and cancer is fueling the demand for advanced drug delivery systems in Japan. These conditions often require long-term treatment involving multiple medications, and optimized drug delivery methods can significantly improve therapeutic outcomes and enhance the quality of life for patients. Factors such as rapid urbanization, ongoing enhancements in the healthcare sector, and extensive research and development (R&D) efforts by industry leaders are also contributing positively to the pharmaceutical drug delivery market in Japan. Collectively, these elements are expected to shape a favorable outlook for market growth in the country over the forecasted period.
Japan Pharmaceutical Drug Delivery Market Segmentation:
Route of Administration Insights:
- Oral Drug Delivery
- Injectable Drug Delivery
- Topical Drug Delivery
- Ocular Drug Delivery
- Pulmonary Drug Delivery
- Implantable Drug Delivery
- Transmucosal Drug Delivery
- Nasal Drug Delivery
Application Insights:
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes
- Respiratory Diseases
- Central Nervous System Disorders
- Autoimmune Diseases
- Others
End User Insights:
- Hospitals
- Ambulatory Surgery Centers
- Home Care Settings
- Diagnostic Centers
- Others
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key Questions Answered in This Report:
- How has the Japan pharmaceutical drug delivery market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Japan pharmaceutical drug delivery market?
- What is the breakup of the Japan pharmaceutical drug delivery market on the basis of route of administration?
- What is the breakup of the Japan pharmaceutical drug delivery market on the basis of application?
- What is the breakup of the Japan pharmaceutical drug delivery market on the basis of end user?
- What are the various stages in the value chain of the Japan pharmaceutical drug delivery market?
- What are the key driving factors and challenges in the Japan pharmaceutical drug delivery?
- What is the structure of the Japan pharmaceutical drug delivery market and who are the key players?
- What is the degree of competition in the Japan pharmaceutical drug delivery market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Japan Pharmaceutical Drug Delivery Market - Introduction
- 4.1 Overview
- 4.2 Market Dynamics
- 4.3 Industry Trends
- 4.4 Competitive Intelligence
5 Japan Pharmaceutical Drug Delivery Market Landscape
- 5.1 Historical and Current Market Trends (2019-2024)
- 5.2 Market Forecast (2025-2033)
6 Japan Pharmaceutical Drug Delivery Market - Breakup by Route of Administration
- 6.1 Oral Drug Delivery
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
- 6.2 Injectable Drug Delivery
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
- 6.3 Topical Drug Delivery
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
- 6.4 Ocular Drug Delivery
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)
- 6.5 Pulmonary Drug Delivery
- 6.5.1 Overview
- 6.5.2 Historical and Current Market Trends (2019-2024)
- 6.5.3 Market Forecast (2025-2033)
- 6.6 Implantable Drug Delivery
- 6.6.1 Overview
- 6.6.2 Historical and Current Market Trends (2019-2024)
- 6.6.3 Market Forecast (2025-2033)
- 6.7 Transmucosal Drug Delivery
- 6.7.1 Overview
- 6.7.2 Historical and Current Market Trends (2019-2024)
- 6.7.3 Market Forecast (2025-2033)
- 6.8 Nasal Drug Delivery
- 6.8.1 Overview
- 6.8.2 Historical and Current Market Trends (2019-2024)
- 6.8.3 Market Forecast (2025-2033)
7 Japan Pharmaceutical Drug Delivery Market - Breakup by Application
- 7.1 Infectious Diseases
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
- 7.2 Cancer
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
- 7.3 Cardiovascular Diseases
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
- 7.4 Diabetes
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
- 7.5 Respiratory Diseases
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2019-2024)
- 7.5.3 Market Forecast (2025-2033)
- 7.6 Central Nervous System Disorders
- 7.6.1 Overview
- 7.6.2 Historical and Current Market Trends (2019-2024)
- 7.6.3 Market Forecast (2025-2033)
- 7.7 Autoimmune Diseases
- 7.7.1 Overview
- 7.7.2 Historical and Current Market Trends (2019-2024)
- 7.7.3 Market Forecast (2025-2033)
- 7.8 Others
- 7.8.1 Historical and Current Market Trends (2019-2024)
- 7.8.2 Market Forecast (2025-2033)
8 Japan Pharmaceutical Drug Delivery Market - Breakup by End User
- 8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
- 8.2 Ambulatory Surgery Centers
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
- 8.3 Home Care Settings
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
- 8.4 Diagnostic Centers
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
- 8.5 Others
- 8.5.1 Historical and Current Market Trends (2019-2024)
- 8.5.2 Market Forecast (2025-2033)
9 Japan Pharmaceutical Drug Delivery Market - Competitive Landscape
- 9.1 Overview
- 9.2 Market Structure
- 9.3 Market Player Positioning
- 9.4 Top Winning Strategies
- 9.5 Competitive Dashboard
- 9.6 Company Evaluation Quadrant
10 Profiles of Key Players
- 10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
- 10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
- 10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
- 10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
- 10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events
11 Japan Pharmaceutical Drug Delivery Market - Industry Analysis
- 11.1 Drivers, Restraints and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
- 11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
- 11.3 Value Chain Analysis
